Avedro
Avedro’s KXL® System for accelerated cross-linking, as well as a family of riboflavin products, have been commercially available since 2010. Refractive correction pioneer and veteran David Muller, PhD, President & CEO, discussed the company’s most recent activities, expressing excitement about Avedro’s PiXL, a non-invasive refractive correction procedure, which uses only eye drops and light. Among other efforts, the company is also developing a Brillion Microscopy system, which would be the first device to measure biomechanical parameters in the eye (on track for 510k submission 4Q 2015).
Presenter:
David Muller, PhD
Dr. Muller recognized the potential of using advanced methods to gently reshape the cornea and in 2007 founded Avedro, Inc., where he serves as the CEO.